Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study
Journal article
Jackson S. et al, (2024), The Lancet Microbe, 5, 655 - 668
Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV.
Journal article
Davis C. et al, (2024), Vaccines, 12
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.
Journal article
Lim YJ. et al, (2024), British journal of haematology
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Journal article
Goodyear CS. et al, (2024), The Lancet. Rheumatology, 6, e339 - e351
Analysis of primary care electronic health record data of people living with hepatitis B virus: infection and hepatocellular carcinoma risk associated with socio-economic deprivation.
Journal article
Campbell C. et al, (2024), Public health, 226, 215 - 227
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients
Journal article
Murray SM. et al, (2024), Journal of Hepatology, 80, 109 - 123
HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.
Journal article
Cargill T. et al, (2023), JHEP reports : innovation in hepatology, 5
CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study
Journal article
Neale I. et al, (2023), mBio, 14
Correction to: Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies.
Journal article
Gillespie IA. et al, (2023), Infectious diseases and therapy
Joint statement in support of hepatitis C human challenge studies.
Journal article
Alter HJ. et al, (2023), The lancet. Gastroenterology & hepatology
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history
Journal article
Hornsby H. et al, (2023), Nature Communications, 14
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.
Journal article
Hamill V. et al, (2023), BMJ (Clinical research ed.), 382
Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies.
Journal article
Gillespie IA. et al, (2023), Infectious diseases and therapy
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Journal article
Barnes E. et al, (2023), Nature Medicine, 29, 1760 - 1774
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination
Journal article
Johnson SA. et al, (2023), Clinical and Experimental Immunology, 212, 249 - 261
An enrichment protocol and analysis pipeline for long read sequencing of the hepatitis B virus transcriptome
Journal article
Ng E. et al, (2023), Journal of General Virology, 104
Defining the key intrahepatic gene networks in HCV infection driven by sex
Journal article
Marchi E. et al, (2023), Gut, 72, 984 - 994
Disparities in care and outcomes for primary liver cancer in England during 2008-2018: a cohort study of 8.52 million primary care population using the QResearch database.
Journal article
Liao W. et al, (2023), EClinicalMedicine, 59
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
Journal article
Murray SM. et al, (2023), Nature Reviews Immunology, 23, 304 - 316
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK.
Journal article
Hamill V. et al, (2023), Liver international : official journal of the International Association for the Study of the Liver, 43, 917 - 927